2021
DOI: 10.23958/ijirms/vol06-i12/1284
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Plasma Assisted Noninvasive Surgery (PANIS) As a New Approach for the Treatment of Conjunctival Concretions: A Clinical Case Series

Abstract: Background and Objective: Plasma is one of the newest therapies recently used. This study aimed to evaluate a quick treatment modality of conjunctival concretions using plasma as a noninvasive procedure. Methods: Six eyes of six patients with conjunctival concretions were evaluated. The procedure was performed using plasma spots generated by the white handpiece of the Plexr device. The eyelid was everted and concretions sublimated by plasma spots from the upper and lower eyelids. Refractive Errors, visual acui… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 9 publications
0
5
0
Order By: Relevance
“…In another research, Inflammatory cytokines in tear and serum has checked 4 times within 6 months follow-up after plasma spots on Rats conjunctiva, and this study also reported no persistent inflammatory responses [29]. After 3 animal studies, human ocular surface diseases have been targeted to treating with atmospheric low-temperature plasma and published case series studies, including conjunctivochalasis, conjunctival cyst, pinguecula, pterygium, punctal occlusion, conjunctival concretion, pseudophakic bullous keratopathy, conjunctival nevus [15,[30][31][32][33][34]. All these novel modalities have been taught to ophthalmologists all over the world, as a safe, office-based and effective approaches [35].…”
Section: Resultsmentioning
confidence: 76%
“…In another research, Inflammatory cytokines in tear and serum has checked 4 times within 6 months follow-up after plasma spots on Rats conjunctiva, and this study also reported no persistent inflammatory responses [29]. After 3 animal studies, human ocular surface diseases have been targeted to treating with atmospheric low-temperature plasma and published case series studies, including conjunctivochalasis, conjunctival cyst, pinguecula, pterygium, punctal occlusion, conjunctival concretion, pseudophakic bullous keratopathy, conjunctival nevus [15,[30][31][32][33][34]. All these novel modalities have been taught to ophthalmologists all over the world, as a safe, office-based and effective approaches [35].…”
Section: Resultsmentioning
confidence: 76%
“…These safety evaluations confirmed the initiation of human trials to use plasma technology for treating ocular surface diseases such as conjunctival cyst, conjunctivochalasis, pinguecula, pseudophakic bullous keratopathy, conjunctival concretion, pterygium, dry eye disease, and conjunctival nevus. A published case series about the PANIS modality (plasma-assisted noninvasive surgery) with an average follow-up of 6 months proved the safety and efficacy of this novel technique for treating common ocular surface diseases [7,[25][26][27][28][29][30][31][32].…”
Section: Discussionmentioning
confidence: 98%
“…The PANIS method has been used to treat ocular surface diseases such as conjunctivochalasis, conjunctival cysts, dry eye disease, pinguecula, conjunctival concretion, pseudophakic bullous keratopathy, pterygium, and conjunctival nevus [36][37][38][39][40][41][42][43][44][45][46].…”
Section: Discussionmentioning
confidence: 99%